中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Zhao, Qun;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Sun, Guogui;  Wu, Yongjuan;  Wang, Meng;  Sun, Ying
收藏  |  浏览/下载：65/0  |  提交时间：2022/01/10
PI3K-AKT pathway alterations are revealed as a potential mechanism of chemoradiation resistance in small cell lung cancer by whole-exome sequencing. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Chen, Ming;  Jin, Ying;  Chen, Yamei;  Hu, Xiao;  Tang, Huarong;  Li, Qian;  Li, Pansong;  Lv, Xinze;  Xia, Xuefeng;  Zhang, Jianjun
收藏  |  浏览/下载：51/0  |  提交时间：2022/01/10
Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Ding, Ke-Feng;  Liu, Yue;  Du, Jinlin;  Zhu, Yuping;  Liu, Zhuo;  Wang, Jianping;  Xu, Dong;  Li, Jun;  Liao, Xiujun;  Sun, Lifeng;  He, Jinjie;  Xiao, Qian;  Wang, Jianwei;  Cao, Hongfeng;  Cai, Yibo;  Cai, Cheng;  Jin, Zhekang;  Yuan, Ying
收藏  |  浏览/下载：53/0  |  提交时间：2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Jiang, Da;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Wu, Xiangyuan;  Gao, Feng;  Sun, Ying;  Hou, Zhiguo
收藏  |  浏览/下载：62/0  |  提交时间：2022/01/10